1. Academic Validation
  2. Novel regulators of hepatic macrophages in liver fibrosis

Novel regulators of hepatic macrophages in liver fibrosis

  • Front Immunol. 2025 Dec 17:16:1705503. doi: 10.3389/fimmu.2025.1705503.
Xiangjun Tang # 1 Meiwen Bai # 1 Xianhong Du # 1 Hong Wang 1 Meifang Liu 1 Xiaoyan Fu 1 Hongxia Zhang 1 Shujuan Liang 1 Liyuan Wang 1
Affiliations

Affiliation

  • 1 Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China.
  • # Contributed equally.
Abstract

Liver fibrosis is a common pathological process resulting from liver damage and subsequent inflammatory responses in various chronic liver diseases, leading to persistent structural and functional abnormalities in the liver. It can further progress to liver cirrhosis and hepatocellular carcinoma. Currently, no effective treatments are available for liver fibrosis, except for liver transplantation. Hepatic macrophages play essential roles in both the development and regression of liver fibrosis. Understanding the mechanisms by which hepatic macrophages regulate liver fibrosis could identify new therapeutic targets. In this review, we aim to summarize recent discoveries regarding the specific molecular mechanisms underlying the progression of liver fibrosis over the past 5 years, with a special focus on monocyte recruitment and macrophage polarization or differentiation, as well as their roles in disease progression.

Keywords

liver fibrosis; macrophage; macrophage polarization; molecular mechanisms; monocyte recruitment.

Figures
Products